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Streptococcus suis infection is an emerging zoonosis in 
Southeast Asia. We report a fatal case of S. suis serotype 
16 infection in a Vietnamese man in 2001.
Streptococcus suis is a gram-positive, facultatively an-aerobic coccus that may cause pneumonia, meningi-
tis, septicemia, and arthritis in pigs. The pig can also be a 
healthy carrier of S. suis in the upper respiratory tract (par-
ticularly the tonsils and nasal cavities), the genital tract, and 
the alimentary tract (1,2). The fi rst case of S. suis infection 
in humans was reported in Denmark in 1968. Since then, 
increasing numbers of cases have been reported in many 
countries, including the Netherlands; the United Kingdom; 
France; Hong Kong Special Administrative Region, Peo-
ple’s Republic of China; Thailand; Taiwan; and the United 
States (3–7). A recent outbreak of S. suis infections in Sich-
uan Province, People’s Republic of China, emphasized the 
importance of S. suis as an emerging zoonosis (8). S. suis 
is also the most important cause of bacterial meningitis in 
adults at the Hospital for Tropical Diseases (HTD) in Ho 
Chi Minh City, Vietnam (N.T.H Mai et al., unpub. data). 
The number of cases is likely underreported and will likely 
increase further with increased awareness and enhanced ca-
pacity to culture and identify S. suis.
The Patient
A 57-year-old unemployed man from Long An Prov-
ince, southern Vietnam, who had a history of alcohol abuse, 
had a 10-day history of abdominal pain, jaundice, anorexia, 
and weight loss. At the time of admission to HTD in 2001, 
the patient was lethargic, his vital signs were stable, and his 
neck was not stiff. Physical examination showed cutaneous 
spider naevi, jaundice, hepatosplenomegaly, and ascites. 
Leukocyte count was 15.3 ×103 cells/μL (70% neutrophils), 
blood urea nitrogen 12.1 mmol/L (reference range 3.57–7.14 
mmol/L), creatinine 150 μmol/L (<115 mmol/L), sodium 
127 mmol/L (135–145 mmol/L), potassium 6.67 mmol/L 
(3.5–5.1 mmol/L), serum aspartate aminotransferase 87 
IU/L (12–30 IU/L), serum alamine aminotransferase 41 
IU/L (13–40 IU/L), and albumin 20 g/L (35–52 g/L). An 
abdominal ultrasound examination showed hepatospleno-
megaly and ascites. Ascitic fl uid was cloudy and con-
tained 5 g/L protein. Results of Gram stain and culture 
of ascitic fl uid were negative. A diagnosis of spontaneous 
bacterial peritonitis associated with alcoholic liver cirrho-
sis was made, and the patient was treated with 2 g/day of 
ceftriaxone. 
Twenty-four hours after admission, acute respiratory 
distress developed. The patient’s family decided to take 
him home because they were unable to pay for further treat-
ment; the patient died on the same day. The blood culture 
(BACTEC 9050 system; Becton Dickinson Microbiology 
Systems, Sparks, MD, USA), which was taken at the time 
of admission, grew S. suis 24 hours after collection. Further 
inquiries into potential pig exposure, after the blood culture 
results were reported, indicated that the patient kept pigs 
near his house and was known to regularly consume por-
tions of the pig that had a high risk of being contaminated, 
such as the intestine.
S. suis was identifi ed on the basis of colony morphol-
ogy, negative katalase reaction, optochin resistance, and 
APIStrep (bioMérieux, Marcy l’Etoile, France). Serotyp-
ing was performed by slide agglutination using specifi c 
antisera (Statens Serum Institute, Copenhagen, Denmark) 
and was positive for serotype 16. Confi rmation of the sero-
type was performed at the International Reference Labora-
tory for S. suis Serotyping, Quebec City, Quebec, Canada 
(M. Gottschalk). This strain was susceptible to penicillin 
(MIC 0.032 mg/L), ceftriaxone (0.064 mg/L), rifampin 
(0.032 mg/L), chloramphenicol (2 mg/L), erythromycin 
(0.064 mg/L), levofl oxacin (0.38 mg/L), and vancomycin 
(0.5 mg/L) but resistant to tetracycline (64 mg/L) by Etest 
(AB-Biodisk, Solna, Sweden) when Clinical Laboratory 
Standard Institute breakpoints were used. On pulsed-fi eld 
gel electrophoresis (PFGE) that used restriction enzyme 
SmaI, this strain showed little similarity with a representa-
tive set of serotype 2 isolates from Vietnam (Figure). Mul-
tilocus sequence typing (MLST) (www.mlst.net) showed 
that the sequence of 5 of 7 alleles of the included house-
keeping genes had not been previously described. Thus, 
this strain was assigned the new sequence type 106. On 
eBURST analysis (www.mlst.net), this sequence type does 
not belong to any of the clonal complexes but is a single-
ton. PCR for detection of the genes encoding the putative 
virulence factors extracellular protein factor (EF) and sui-
lysin were negative. Results of Western blot for detection 
of muramidase-released protein (MRP) and EF, using rab-
bit polyclonal antibody against MRP and EF (provided by 
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H. Smith, the Netherlands), were also negative. S. suis se-
rotype 2 strains 31533 and 89-1591 (provided by M. Gott-
schalk, Canada) were used as positive and negative con-
trols respectively .
The total number of human S. suis infections reported 
until August 2006 was ≈400, and nearly 90% of these cases 
occurred in China, Thailand, Hong Kong, Taiwan, and the 
Netherlands (4). These data did not include at least 200 
cases of S. suis infection in Vietnam (C. Schultsz, unpub. 
data). At present, 33 capsular serotypes of S. suis have been 
recognized (1,4). S. suis serotype 2 is considered to be the 
most pathogenic to pigs and humans. All human cases of 
S. suis infection for which serotyping was available were 
caused by S. suis serotype 2, except for 1 case of serotype 1 
(9), 1 case of serotype 4 (3), and 1 case of serotype 14 (6). 
Among 116 cases of S. suis meningitis seen at HTD from 
1997 through 2005, 115 were caused by serotype 2 and 1 
by serotype 14. 
S. suis serotype 2 can cause meningitis, septicemia 
and septic shock, arthritis, endocarditis, pneumonia, endo-
phthalmitis, and cellulitis in humans (3,5,8). The mortality 
rate for S. suis serotype 2 meningitis is <10% (10), but it 
can reach 70% among patients with septicemia and septic 
shock (11). The exact route of infection for humans is not 
known. Cases have been linked to accidental inoculation 
through skin injuries, for example, during occupational 
exposure to pigs and pork, but inhalation of aerosols and 
ingestion of contaminated food have also been suggested 
(3,9,11,12). Preexisting medical conditions, such as alco-
holism and liver cirrhosis, as was present in our patient, or 
a prior splenectomy may predispose to severe infection.
Serotype 16 has never been isolated from humans and, 
to our knowledge, has also rarely been reported as a cause 
of invasive disease in pigs. One isolate of S. suis serotype 
16 was reported from a diseased pig in Germany and 4 iso-
lates from slaughter pigs in South Korea (13,14). The S. 
suis serotype 16 strain was sensitive to all antimicrobial 
agents tested except tetracycline, as has been reported for 
serotype 2 isolates (5). PFGE results showed that this hu-
man serotype 16 isolate was unrelated to human serotype 
2 isolates. On MLST, this isolate had a new sequence type 
that did not belong to any of the clonal complexes. In con-
trast, most serotype 2 isolates reported so far belong to 
clonal complex 1 (www.mlst.net). Taken together, these 
results suggest that capsule switch, such as has been ob-
served for S. pneumoniae, does not explain the emergence 
of invasive isolates of a different serotype. In addition, the 
PCR and Western blot analyses indicate that the serotype 2 
capsule, EF, MRP, or suilysin is not required for virulence 
of S. suis in humans, as has also been shown in pigs. 
Conclusions
S. suis infection is an emerging zoonosis in Asia. 
Strains with serotype 16 are among those capable of infect-
ing humans.
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